The investigation into Lance Armstrong and his former US Postal Service team’s alleged doping widened Tuesday when U.S. Food and Drug Administration officials, federal prosecutors and U.S. Anti-Doping Agency representatives met with French anti-doping authorities at the International Criminal Police Organization offices in Lyon, France.

Advertisement

Bicycling Newsletters

According to reports by the Associated Press and the French sports daily L’Equipe, USFDA agent Jeff Novitzky, federal prosecutor Doug Miller and USADA CEO Travis Tygart interviewed Francoise Lasne, director of the French Chatenay-Malabry laboratory. They also interviewed testing director Jean-Pierre Verdy and longtime president of the French Anti-Doping Association Pierre Brodry.

The interviews likely centered on doping in cycling—specifically, on seven-time Tour de France winner Lance Armstrong, who has become the center of a federal investigation after former teammate Floyd Landis alleged this spring that Armstrong doped and encouraged others to do so during his career.

Novitzky—who led the BALCO doping investigation that eventually brought down American sprinter Marion Jones—has now focused on Armstrong and whether he and the U.S. Postal team that he led from 1999 to 2004 used taxpayer money to fund a doping ring. If proven, Armstrong could face fraud charges.

Lasne helped create a urine test to detect the performance-enhancing drug EPO. In 2005, her lab found traces of EPO in numerous Armstrong tests from the 1999 Tour.

Little is known about the specifics of the meeting, and neither Novitzky nor other members of the American contingent would speak on record.

One French official, however, spoke off the record saying that the French officials would “share everything we have in the fridges, in the freezers, everything, everywhere.”

Former AFLP president Brodry has often invited Armstrong to authorize further tests of the sample to confirm or refute the findings. Armstrong refuses, claiming that he trust neither the French lab nor the accuracy of the now 11-year-old sample.

The AFLD has announced a press conference with its current president Bruno Genevois to present its annual report and to answer questions regarding current developments.